134002-26-9
Product Name:
3-(S)-(+)-(1-Carbamoyl-1,1-diphenylmethyl)pyrroloidine-L-(+)-tartarate
Formula:
C22H26N2O7
Inquiry
SAFETY INFORMATION
| Signal word | Warning |
|---|---|
| Pictogram(s) |
 Flame Over Circle Oxidizers GHS03  Health Hazard GHS08  Environment GHS09 |
| GHS Hazard Statements |
H272:Oxidising liquids;Oxidising solids H317:Sensitisation, Skin H350:Carcinogenicity H410:Hazardous to the aquatic environment, long-term hazard |
| Precautionary Statement Codes |
P201:Obtain special instructions before use. P202:Do not handle until all safety precautions have been read and understood. P221:Take any precaution to avoid mixing with combustibles/… P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P272:Contaminated work clothing should not be allowed out of the workplace. P363:Wash contaminated clothing before reuse. P302+P352:IF ON SKIN: wash with plenty of soap and water. P308+P313:IF exposed or concerned: Get medical advice/attention. P403:Store in a well-ventilated place. |
COMPUTED DESCRIPTORS
| Molecular Weight | 430.5 g/mol |
|---|---|
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 7 |
| Exact Mass | 430.17400117 g/mol |
| Monoisotopic Mass | 430.17400117 g/mol |
| Topological Polar Surface Area | 170 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 472 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 2 |
| Compound Is Canonicalized | Yes |
RELATED SUPPLIERS
Vepan Pharmatech Pvt Ltd
1Y
product:3-(S)-(+)- (-1-carbamoyl-1, 1-diphenylmethyl)- pyrrolidine-L- tartarate
Deepa Pharma
1Y
product:(S)-alpha,alpha-Diphenyl-3-pyrrolidineacetamide L-tartaric acid salt 134002-26-9 98%
Venkatasai Life Sciences
1Y
product:134002-26-9 (S)-alpha,alpha-Diphenyl-3-pyrrolidineacetamide L-tartaric acid salt 99%